Articolul precedent |
Articolul urmator |
641 1 |
Ultima descărcare din IBN: 2022-08-20 13:20 |
SM ISO690:2012 ЕНГАШЕВ, Сергей, ЕНГАШЕВА, Екатерина, КОЛЕСНИКОВ, В., ЛОПТЕВА, М.. Иверсан – раствор для орального применения при нематодозах овец. In: Actual problems of zoology and parasitology: achievements and prospects, 13 octombrie 2017, Chișinău. Chișinău, Republica Moldova: Institutul de Zoologie, 2017, pp. 248-250. ISBN 978-9975-66-590-2. DOI: https://doi.org/10.53937/9789975665902.53 |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Actual problems of zoology and parasitology: achievements and prospects 2017 | ||||||
Simpozionul "Actual problems of zoology and parasitology: achievements and prospects" Chișinău, Moldova, 13 octombrie 2017 | ||||||
|
||||||
DOI:https://doi.org/10.53937/9789975665902.53 | ||||||
Pag. 248-250 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
The new drug Iversan in manufacturing experience on sheep showed higher anthelmintic effect (IE = 98.7%, EE = 86.6%) than known drug Ivomek. |
||||||
Cuvinte-cheie sheep, nematodes, efficiency, iversan, ivomek |
||||||
|
Cerif XML Export
<?xml version='1.0' encoding='utf-8'?> <CERIF xmlns='urn:xmlns:org:eurocris:cerif-1.5-1' xsi:schemaLocation='urn:xmlns:org:eurocris:cerif-1.5-1 http://www.eurocris.org/Uploads/Web%20pages/CERIF-1.5/CERIF_1.5_1.xsd' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' release='1.5' date='2012-10-07' sourceDatabase='Output Profile'> <cfResPubl> <cfResPublId>ibn-ResPubl-65855</cfResPublId> <cfResPublDate>2017</cfResPublDate> <cfStartPage>248</cfStartPage> <cfISBN>978-9975-66-590-2</cfISBN> <cfURI>https://ibn.idsi.md/ro/vizualizare_articol/65855</cfURI> <cfTitle cfLangCode='RU' cfTrans='o'>Иверсан – раствор для орального применения при нематодозах овец</cfTitle> <cfKeyw cfLangCode='RU' cfTrans='o'>sheep; nematodes; efficiency; iversan; ivomek</cfKeyw> <cfAbstr cfLangCode='EN' cfTrans='o'><p><em>The new drug Iversan in manufacturing experience on sheep showed higher anthelmintic effect (IE = 98.7%, EE = 86.6%) than known drug Ivomek.</em></p></cfAbstr> <cfResPubl_Class> <cfClassId>eda2d9e9-34c5-11e1-b86c-0800200c9a66</cfClassId> <cfClassSchemeId>759af938-34ae-11e1-b86c-0800200c9a66</cfClassSchemeId> <cfStartDate>2017T24:00:00</cfStartDate> </cfResPubl_Class> <cfResPubl_Class> <cfClassId>e601872f-4b7e-4d88-929f-7df027b226c9</cfClassId> <cfClassSchemeId>40e90e2f-446d-460a-98e5-5dce57550c48</cfClassSchemeId> <cfStartDate>2017T24:00:00</cfStartDate> </cfResPubl_Class> <cfPers_ResPubl> <cfPersId>ibn-person-59620</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2017T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-59682</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2017T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-59691</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2017T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-59692</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2017T24:00:00</cfStartDate> </cfPers_ResPubl> </cfResPubl> <cfPers> <cfPersId>ibn-Pers-59620</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-59620-1</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2017T24:00:00</cfStartDate> <cfFamilyNames>Енгашев</cfFamilyNames> <cfFirstNames>Сергей</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-59682</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-59682-1</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2017T24:00:00</cfStartDate> <cfFamilyNames>Енгашева</cfFamilyNames> <cfFirstNames>Екатерина</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-59691</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-59691-1</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2017T24:00:00</cfStartDate> <cfFamilyNames>Колесников</cfFamilyNames> <cfFirstNames>В.</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-59692</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-59692-1</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2017T24:00:00</cfStartDate> <cfFamilyNames>Лоптева</cfFamilyNames> <cfFirstNames>М.</cfFirstNames> </cfPersName_Pers> </cfPers> </CERIF>